Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA: 688506)

China flag China · Delayed Price · Currency is CNY
193.00
-4.76 (-2.41%)
Nov 11, 2024, 9:30 AM CST
106.42%
Market Cap 77.74B
Revenue (ttm) 5.85B
Net Income (ttm) 3.80B
Shares Out 401.00M
EPS (ttm) 9.52
PE Ratio 20.36
Forward PE 20.61
Dividend n/a
Ex-Dividend Date n/a
Volume 1,954,121
Open 198.20
Previous Close 197.76
Day's Range 186.01 - 198.27
52-Week Range 90.31 - 238.80
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Oct 29, 2024

About Sichuan Biokin Pharmaceutical Co.,Ltd.

Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally. Sichuan Biokin Pharmaceutical Co.,Ltd. was founded in 2006 and is based in Chengdu, China. [Read more]

Sector Healthcare
Founded 2006
Employees 2,086
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688506
Full Company Profile

Financial Performance

In 2023, Sichuan Biokin Pharmaceutical Co.,Ltd.'s revenue was 561.87 million, a decrease of -20.11% compared to the previous year's 703.28 million. Losses were -780.50 million, 176.4% more than in 2022.

Financial Statements

News

There is no news available yet.